Delivery Order SPE2DB25D2207-SPE2DB25FQRRF
- Not listed
- The Defense Logistics Agency awarded a $1,364.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of HEXTEND 6% Lactated Electrolyte solution in 500ml bags. This is a non-set-aside competitive award with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,354.58 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of HEXTEND 6% Lactated Electrolyte solution in 500mL bags. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 26, 2025. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $1,277.64 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Hextend 6% Lactated Electrolyte Solution in 500ml bags. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's Corporate Office location in...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $6,175.00 order is for the supply of HEXTEND 6%-LACT ELEC BAG 500ML, a specialty medical product. The order has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Hextend LAC 6% 500mL in quantities of 12 units, with a ceiling value of $7,159.27. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, utilizing a competitive award process with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- This delivery order, awarded July 22, 2025, to AmerisourceBergen Drug Corp represents a $8,127.48 firm fixed price procurement of HEXTEND LAC 6% 500ML in quantities of 12 units. The contract is funded through the Defense Logistics Agency's Medical Supply Chain division and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and carries an ultimate completion date of July 22,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,741.03 to AmerisourceBergen Drug Corp for HEXTEND LAC 6% 500ML (12-pack units) with a firm fixed price contract type. This award, issued on July 28, 2025, carries an ultimate completion date of the same day and was competitively awarded without set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $2,155.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561389131 HEXTEND 6%-LACT ELEC BAG 500ML. The prime contractor will deliver the requested pharmaceutical products from its Conshohocken, Pennsylvania facility by July 3, 2023 in support of the Department of Defense's logistics needs. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the U.S....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HEXTEND LAC6%500ML 12S pharmaceutical products. The firm-fixed-price contract has a potential value of $14,041.30 and a completion date of February 21, 2024. This order is part of Amerisourcebergen's broader work providing pharmaceutical products and medical supplies to support DLA's programs and military...
- This federal contract award, identified as SPE2DB22D3301|SPE2DB23FX5VA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of Cencora, Inc. The contract is for the delivery of HEXTEND 6%-LACT ELEC BAG 500ML medical supplies, with a ceiling value of $3,318.07. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of pharmaceutical...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB25FQRRFDelivery Order
The Defense Logistics Agency awarded a $2,015.22 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of HEXTEND 6% Lactated Electrolyte solution in 500mL bags. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal medical procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vehicle enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. HEXTEND 6% Lactated Electrolyte solution is a critical crystalloid fluid used in military and trauma medicine for volume resuscitation and fluid management in deployed and clinical settings, making this a strategically important medical commodity for the Defense Health Agency and broader DoD healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/4/25 |